Growth Metrics

Omeros (OMER) Free Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 60.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 88.70%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.72%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 66.37%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.98%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 137.65%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 59.57%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 59.57%
Dec 31, 2025 -37.36%
Sep 30, 2025 42.41%
Jun 30, 2025 52.30%
Mar 31, 2025 14.24%
Dec 31, 2024 16.99%
Sep 30, 2024 1.90%
Jun 30, 2024 -41.23%
Mar 31, 2024 -123.97%
Dec 31, 2023 -37.60%
Sep 30, 2023 -23.62%
Jun 30, 2023 -67.53%
Mar 31, 2023 1,248.81%
Dec 31, 2022 -38.85%
Sep 30, 2022 -11.24%
Jun 30, 2022 29.66%
Mar 31, 2022 62.27%
Dec 31, 2021 0.64%
Sep 30, 2021 32.13%
Jun 30, 2021 26.66%
Mar 31, 2021 -337.34%
Dec 31, 2020 20.07%
Sep 30, 2020 -363.09%
Jun 30, 2020 -126.18%
Mar 31, 2020 29.88%
Dec 31, 2019 6.95%
Sep 30, 2019 79.54%
Jun 30, 2019 46.37%
Mar 31, 2019 -14.38%
Dec 31, 2018 -493.24%
Sep 30, 2018 -229.19%
Jun 30, 2018 -270.26%
Mar 31, 2018 10.14%
Dec 31, 2017 61.76%
Sep 30, 2017 0.30%
Jun 30, 2017 34.50%
Mar 31, 2017 23.18%
Dec 31, 2016 34.48%
Sep 30, 2016 23.18%
Jun 30, 2016 22.99%
Mar 31, 2016 4.85%
Dec 31, 2015 -6.02%
Sep 30, 2015 8.09%
Jun 30, 2015 -9.11%
Mar 31, 2015 -56.81%
Dec 31, 2014 -4,227.00%
Sep 30, 2014 -43.89%
Jun 30, 2014 -62.53%
Mar 31, 2014 -23.07%
Dec 31, 2013 97.25%
Sep 30, 2013 -47.99%
Jun 30, 2013 -5.15%
Mar 31, 2013 -62.38%
Dec 31, 2012 -78.21%
Sep 30, 2012 -82.09%
Jun 30, 2012 -30.69%
Mar 31, 2012 34.83%
Dec 31, 2011 -212.60%
Sep 30, 2011 32.02%